S100A9 and chronic obstructive pulmonary disease: To dissect IL6‐AS1/S100A9 axis in COPD pathogenesis, we administered paquinimod (S100A9 inhibitor blocking RAGE/TLR4 interaction) [18] via intratracheal instillation during CS exposure in IL6‐AS1 mice (Figure 7A).